Toronto: Human Amyloid Imaging Conference Showcases a Maturing Field Toronto: Ah, The Devil in the Details Toronto: Last Gift to Science—Hospice Patients Validate Amyloid Ligand Toronto: Sister 18F Ligands Jostle for Primacy Toronto: HAI Amyloid Imaging ...
Miami: Women Rock at Human Amyloid Imaging Meeting Miami: Amyloid in the Aging Brain—What Does It Mean? Miami: Multimodal Imaging, New Way to Test Amyloid Hypothesis Miami: Astrocytes, Antidepressants, Microbleeds, and More Miami: Updates on J-ADNI, 18F ...
News Focus: 2012 Human Amyloid Imaging Conference Miami: Amyloid PET in the Clinic: What Are the Issues? Miami: Scan and Tell? Amyloid Imaging Confronts Disclosure Dilemma Miami: Can the Naked Eye Tell When a Scan Is Positive? Miami: When Does Amyloid ...
Solanezumab Selected for Alzheimer’s A4 Prevention Trial HAI—Spotlight on Tau Tracers at Human Amyloid Imaging Meeting HAI—Amyloid Imaging in the Clinic: New Guidelines and Data HAI—Sharper Curves: Revamping a Biomarker Staging Model HAI—Standardizing ...
Boston: Clinical Trial Results for Dimebon Unveiled Boston: Resting State MRI Shows Loss of Network Connectivity Early in AD American Academy of Neurology: 2007 Annual Meeting ...
A deletion in chromosome 22 points to new genetic risk factors for Parkinson's disease.
FUS, a protein tied to neurodegeneration, normally mends DNA breaks, according to a paper in Nature Neuroscience.
It's not just for neurodevelopment anymore. Death receptor 6—known for pruning axons—also trims unused connections in adulthood, hinting at a function in Alzheimer's.
Proposed preclinical stages for Alzheimer’s disease predict well who is most likely to progress to Alzheimer’s dementia.
What’s better for future treatment of Parkinson’s: patient-derived or banked iPSCs? In comparison, patient’s own come out on top.
A new RNA interference therapy for amyotrophic lateral sclerosis has some success in mice and monkeys.
In the first study of its kind, researchers found a surprisingly low incidence of Lewy body dementias in a U.S. population.
The Alzheimer’s Disease Neuroimaging Initiative has released whole genome sequences from 809 study volunteers.
Interested in Parkinson's? Apply for access to data and tissue samples, and funds to study them, from the Michael J. Fox Foundation.
By tracking Alzheimer’s research funding internationally, a new database could help sponsors coordinate research efforts.
No filters selected